Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof - EP4108671

The patent EP4108671 was granted to Moderna on Nov 20, 2024. The application was originally filed on Oct 3, 2011 under application number EP22173763A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4108671

MODERNA
Application Number
EP22173763A
Filing Date
Oct 3, 2011
Status
Granted And Under Opposition
Oct 18, 2024
Grant Date
Nov 20, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BIONTECHAug 20, 2025WILKADMISSIBLE
MAIWALDAug 20, 2025MAIWALDADMISSIBLE
PATENT BOUTIQUEAug 20, 2025PATENT BOUTIQUEADMISSIBLE
PFIZERAug 20, 2025PFIZERADMISSIBLE
WITHERS & ROGERSAug 20, 2025TOMBLINGADMISSIBLE
SANOFIFeb 28, 2025CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (42) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS20130614044-
DESCRIPTIONUS4270537
DESCRIPTIONUS4596556
DESCRIPTIONUS4790824
DESCRIPTIONUS4886499
DESCRIPTIONUS4940460
DESCRIPTIONUS4941880
DESCRIPTIONUS5015235
DESCRIPTIONUS5064413
DESCRIPTIONUS5141496
DESCRIPTIONUS5190521
DESCRIPTIONUS5312335
DESCRIPTIONUS5328483
DESCRIPTIONUS5334144
DESCRIPTIONUS5339163
DESCRIPTIONUS5383851
DESCRIPTIONUS5417662
DESCRIPTIONUS5466220
DESCRIPTIONUS5480381
DESCRIPTIONUS5503627
DESCRIPTIONUS5520639
DESCRIPTIONUS5527288
DESCRIPTIONUS5569189
DESCRIPTIONUS5599302
DESCRIPTIONUS5649912
DESCRIPTIONUS5704911
DESCRIPTIONUS5893397
DESCRIPTIONUS5993412
DESCRIPTIONWO9713537
DESCRIPTIONWO9737705
DESCRIPTIONWO9934850
OPPOSITIONEP2578685
OPPOSITIONEP3611266
OPPOSITIONUS8999380
OPPOSITIONWO2007024708
OPPOSITIONWO2008083949
OPPOSITIONWO2011071931
OPPOSITIONWO2012019168
OPPOSITIONWO2012045075
OPPOSITIONWO2013039861
OPPOSITIONWO2013052523
SEARCHWO2007024708

Non-Patent Literature (NPL) Citations (59) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ALBRECHT, Immunotherapy, (20100000), vol. 2, no. 6, pages 795 - 8-
DESCRIPTION- CARILLO et al., SIAM J. Applied Math., (19880000), vol. 48, page 1073-
DESCRIPTION- FUKUHARA et al., Biochemistry, (19620000), vol. 1, no. 4, pages 563 - 568-
DESCRIPTION- GREENE et al., Protective Groups in Organic Synthesis, M. Stockton Press, (19910000), vol. 2d-
DESCRIPTION- Journal of Pharmaceutical Science, (19770000), vol. 66, page 2-
DESCRIPTION- MUSUNURU K, "From noncoding variant to phcnotypc via SORT1 at the lpl3 cholesterol locus", Nature, (20100000), vol. 466, pages 714 - 721-
DESCRIPTION- OGATA et al., Journal of Organic Chemistry, (20090000), vol. 74, pages 2585 - 2588-
DESCRIPTION- "Oligonucleotide synthesis: methods and applications", Methods in Molecular Biology, Humana Press, (20050000), vol. 288-
DESCRIPTION- PURMAL et al., Nucleic Acids Research, (19940000), vol. 22, no. 1, pages 72 - 78-
DESCRIPTION- Remington's Pharmaceutical Sciences, Mack Publishing Company, (19850000), page 1418-
DESCRIPTION- ROZENSKI, JCRAIN, PMCCLOSKEY, J., "The RNA Modification Database: 1999 update", Nucl Acids Res, (19990000), vol. 27, pages 196 - 197-
DESCRIPTION- T. HIGUCHIV. STELLA, "Pro-drugs as Novel Delivery Systems", A.C.S. Symposium Series, vol. 14-
DESCRIPTION- XU et al., Tetrahedron, (19920000), vol. 48, no. 9, pages 1729 - 1740-
OPPOSITION- Anonymous, "Dedicated to providing specialty chemicals to advance the life sciences", Berry & Associates, (20090101), pages 1 - 288, XP093176759-
OPPOSITION- Anonymous, "Moderna Annual Report 2022", Moderna, (20230224), Moderna, URL: https://s29.q4cdn.com/435878511/files/doc_financials/2022/ar/Moderna-Annual-Report-2022.pdf, XP093308753-
OPPOSITION- Brand Reindert C, Klootwijk Jacobus, Biochemischlaboratorium Rudi J Planta, Edward B, Maden H, " Biosynthesis of a Hypermodified Nucleotide in Saccharomyces carlsbergensis 17 S and HeLa-Cell 18 S Ribosomal Ribonucleic Acid", Biochem. J, (19780101), vol. 169, pages 71 - 77, XP055960175-
OPPOSITION- D13 - EP1979364 claims-
OPPOSITION- D14 - D11’s priority document-
OPPOSITION- D15 - EP3112467 claims-
OPPOSITION- D16 - EP3287525 claims-
OPPOSITION- D18 - Moderna - BioNTech EP 949 NL-
OPPOSITION- D20 - Opposition Division decision for EP3590949-
OPPOSITION- D24 - EPO article regarding European Inventor Finalists 2022-
OPPOSITION- D26 - Cellscript and Moderna Sublicense Agreement-
OPPOSITION- D29 - assignment agreement-
OPPOSITION- D31 - Expert opinion-
OPPOSITION- D40 - Correction of inventorship of US 61 /404,413-
OPPOSITION- D46a - Advanced Information for the Nobel Prize for Physiology or Medicine 2023.-
OPPOSITION- D46 - Press Release for the Nobel Prize for Physiology or Medicine 2023 (https://www.nobelprize.org/prizes/medicine/2023/advanced- information/)-
OPPOSITION- D47 - Expert declaration by Prof. Dr. Wahle-
OPPOSITION- D48 - Disclosure of WO 2007/024708-
OPPOSITION- D50a - Claims filed 9 August 2022-
OPPOSITION- D50 - Patentee’s letter to the EPO dated 27 September 2023-
OPPOSITION- D51 - Patentee’s letter to the EPO dated 12 August 2024-
OPPOSITION- D52 - Table providing basis for the claims submitted by the applicant of WO 2007/024708-
OPPOSITION- David Broide, "11: Prospects for TLR9- Based Immunotherapy for Asthma and Allergy", David Broide, Shizuo Akira (Editor), Ken J. Ishii (Editor), Nucleic Acids in Innate Immunity, 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA , CRC PRESS-TAYLOR & FRANCIS GROUP , (20080101), pages 183 - 196, ISBN 978-1-4200-6825-2, XP009563183-
OPPOSITION- Ishii, Ken J. ; Akira, S., "2. Antiviral Signaling through TLRs and RLHs", Ishii, Ken J. ; Akira, S., Shizuo Akira (Editor), Ken J. Ishii (Editor), Nucleic Acids in Innate Immunity, 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA , CRC PRESS-TAYLOR & FRANCIS GROUP , (20080101), pages 17 - 30, ISBN 978-1-4200-6825-2, XP009563182-
OPPOSITION- LIMBACH P A, CRAIN P F, MCCLOSKEY J A, "SUMMARY: THE MODIFIED NUCLEOSIDES OF RNA", Nucleic Acids Research, Information Retrieval Ltd., (19940625), vol. 22, no. 12, ISSN 0305-1048, pages 2183 - 2196, XP001152667-
OPPOSITION- LUDWIG J., "A SIMPLE ONE FLASK SYNTHESIS OF NUCLEOSIDE 5'-TRIPHOSPHATES FROM UNPROTECTED NUCLEOSIDES VIA NUCLEOSIDE 5-CYCLOTRIPHOSPHATES.", BIOPHOSPHATES AND THEIR ANALOGUES - SYNTHESIS, STRUCTURE,METABOLISM AND ACTIVITY., ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, NL , (19870101), vol. 03., pages 201 - 204., XP000605931-
OPPOSITION- Yarian Connie S., Mufeed M. Basti, Robert J. Cain, Ghazala Ansari, Richard H. Guenther, Elzbieta Sochacka, Grazyna Czerwinska, Andrzej Malkiewicz, Paul F. Agris, "Structural and functional roles of the N1- and N3-protons of Ψ at tRNA's position 39 ", Nucleic Acids Research, (19990901), vol. 27, no. 17, pages 3543 - 3549, XP055959841-
OPPOSITION- Diebold Sandra S, Massacrier Catherine, Akira Shizuo, Paturel Carine, Morel Yannis, Reis e Sousa Caetano, "Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides.", European Journal of Immunology, Wiley-VCH, Hoboken, USA, Hoboken, USA, (20061201), vol. 36, no. 12, doi:10.1002/eji.200636617, ISSN 0014-2980, pages 3256 - 3267, XP008101287
OPPOSITION- Pascolo Steve, "Vaccination with messenger RNA (mRNA)", Toll-like receptors (TLRs) and innate immunity, Berlin [u.a.] : Springer, DE, DE , (20080101), vol. 183, doi:10.1007/978-3-540-72167-3_11, ISBN 978-3-540-72166-6, pages 221 - 235, XP001538300
OPPOSITION- MILLIGAN J F, UHLENBECK O C, "SYNTHESIS OF SMALL RNAS USING T7 RNA POLYMERASE", Methods in Enzymology, Elsevier, Academic Press, NL, NL , (19890101), vol. 180, doi:10.1016/0076-6879(89)80091-6, ISBN 978-0-12-805382-9, pages 51 - 62, XP008025566
OPPOSITION- Yamamoto A. et al, "Current prospects for mRNA gene delivery", European journal of pharmaceutics and biopharmaceutics, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM., NL, NL , (20090301), vol. 71, no. 3, doi:10.1016/j.ejpb.2008.09.016, ISSN 0939-6411, pages 484 - 489, XP025992169
OPPOSITION- Katalin Karikó, Michael Buckstein, Houping Ni, Drew Weissman, "Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA", Immunity, Cell Press, AMSTERDAM, NL, AMSTERDAM, NL , (20050801), vol. 23, no. 2, doi:10.1016/j.immuni.2005.06.008, ISSN 1074-7613, pages 165 - 175, XP055548954
OPPOSITION- Pang Henrianna, Ihara Makoto, Kuchino Yoshiyuki, Nishimura Susumu, Gupta Ramesh, Woese Carl R, Mccloskey James A, "Structure of a Modified Nucleoside in Archaebacterial tRNA Which Replaces Ribosylthymine", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (19820410), vol. 257, no. 7, doi:10.1016/S0021-9258(18)34820-8, pages 3589 - 3592, XP093308741
OPPOSITION- Hennig Mirko, Scott Lincoln G, Sperling Edit, Bermel Wolfgang, Williamson James R, "Synthesis of 5-Fluoropyrimidine Nucleotides as Sensitive NMR Probes of RNA Structure", Journal of the American Chemical Society, ACS Publications, (20071201), vol. 129, no. 48, doi:10.1021/ja073825i, ISSN 0002-7863, pages 14911 - 14921, XP093295185
OPPOSITION- ALEXOPOULOU L, ET AL., "Recognition of double-stranded RNA and activation of NF-kB by toll-like receptor 3", Nature, (20011018), vol. 413, doi:10.1038/35099560, pages 732 - 738, XP002968529
OPPOSITION- KARIKÓ KATALIN ET AL, "Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.", Molecular Therapy, Nature Publishing Group, GB, GB , (20081101), vol. 16, no. 11, doi:10.1038/mt.2008.200, ISSN 1525-0024, pages 1833 - 1840, XP002598556
OPPOSITION- Lebre Maria C., Van Der Aar Angelic M.G., Van Baarsen Lisa, Van Capel Toni M.M., Schuitemaker Joost H.N., Kapsenberg Martien L., De Jong Esther C., "Human Keratinocytes Express Functional Toll-Like Receptor 3, 4, 5, and 9", Journal of Investigative Dermatology, Elsevier, (20070201), vol. 127, no. 2, doi:10.1038/sj.jid.5700530, ISSN 0022-202X, pages 331 - 341, XP093144547
OPPOSITION- Conrad Frank, Hanne Andreas, Gaur Rajesh K., Krupp Guido, "Enzymatic synthesis of 2′-modified nucleic acids: identification of important phosphate and ribose moieties in RNase P substrates", Nucleic Acids Research, Information Retrieval Ltd., (19950101), vol. 23, no. 11, doi:10.1093/nar/23.11.1845, ISSN 0305-1048, pages 1845 - 1853, XP093033590
OPPOSITION- Mccloskey J. A., Graham David E, Zhou Shaolian, Crain Pamela F, Ibba Michael, Konisky Jordan, Söll Dieter, Olsen Gary J, "Post-transcriptional modification in archaeal tRNAs: identities and phylogenetic relations of nucleotides from mesophilic and hyperthermophilic Methanococcales", Nucleic Acids Research, (20011115), vol. 29, no. 22, doi:10.1093/nar/29.22.4699, pages 4699 - 4706, XP093032711
OPPOSITION- Sprinzl Mathias, Vassilenko Konstantin S., "Compilation of tRNA sequences and sequences of tRNA genes", Nucleic Acids Research, Oxford University Press, England, England, doi:10.1093/nar/gki012, (20050101), pages 148 - 153, Nucleic Acids Research, URL: https://watermark.silverchair.com/26-1-148.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAtUwggLRBgkqhkiG9w0BBwagggLCMIICvgIBADCCArcGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMoNLP7qBIwNEqjfciAgEQgIICiHNcIZyZBCFA3Z0ttK4G_EIDDZIfls0gK8p2CTrPMgaUovPzSPYuM8ithMDg4QmOH9KDS8x_tdY-sw9FLD5WwR84-FUu0W2tW5baC-SrgITtSXI1r_d37qwU1i_6nDia5koxmgxOvCv9Ff6yMGPp9M99IQnLqztV8InPlY4ilSXp6fvqUHqEOpLLtWKSugrJm_nz_B3vjPf40uW2qk3Imd7rlz6hNrkEjHroaE_bgdAwWDmTp45wTRcMunKDaTphWbwhYuYJOL1IPs1Y6JZaCnvo1o1ghn2cn5lQDIOFYJlTTM4uxlIyZ6gOiy-CaCDkMZWW6XsaHucJOodXv12AyfVdreuVPf8oBW5W93qd3H438ZlFASySj7sBzcRrqiOIwIZJ_ZSR7Fkl-OlZBcOzC4yxZMfVV16o3NTB7J6QdSL2NbqL0J5oDrCYFNoKhCCqmYr-XbLerUFb4WP423wbEWkWmkLy8UdHSdUY9gnEWbVNlu9htiRg_u14aPgeI5RjcTYMW3LT4wdXwjvTlTL34s4vm7u4bYQJ_4hnP3Lz3uiAa6RY7JingJTXs_-ltL1Ta_lRVBoQvbJrmEsJ-XwIY-iOjW-CVZMUoEQO0jTEq5A-o__uNlN7RV3mOeabPoiG4otJ4T7DT0YA_b7CMevHyviNWdKGvlxytGhezDC3q2AkJaed3QZXQvb4GjxhHjcXzfrz88tm44cljtGO87tcjR7_tHyyngO8qHV-RQr5LE_dUFr8k25kxaRl0GUroVtZGUd8f_oqWAflth6zVYN4UUv, (20230317), XP093032707
OPPOSITION- Helm M., "Post-transcriptional nucleotide modification and alternative folding of RNA", Nucleic Acids Research, Information Retrieval Ltd., (20060130), vol. 34, no. 2, doi:10.1093/nar/gkj471, ISSN 0305-1048, pages 721 - 733, XP093028815
OPPOSITION- Oliva R., Cavallo Luigi, Tramontano Anna, "Accurate energies of hydrogen bonded nucleic acid base pairs and triplets in tRNA tertiary interactions", Nucleic Acids Research, Information Retrieval Ltd., (20060206), vol. 34, no. 3, doi:10.1093/nar/gkj491, ISSN 0305-1048, pages 865 - 879, XP093028810
OPPOSITION- Wurm Jan Philip, Meyer Britta, Bahr Ute, Held Martin, Frolow Olga, Kötter Peter, Engels Joachim W., Heckel Alexander, Karas Michael, Entian Karl-Dieter, Wöhnert Jens, "The ribosome assembly factor Nep1 responsible for Bowen-Conradi syndrome is a pseudouridine-N1-specific methyltransferase", Nucleic Acids Research, Information Retrieval Ltd., (20100401), vol. 38, no. 7, doi:10.1093/nar/gkp1189, ISSN 0305-1048, pages 2387 - 2398, XP093032700
OPPOSITION- S. DIEBOLD ET AL., "Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA", Science - Author Manuscript, American Association for the Advancement of Science, US, US , (20040305), vol. 303, doi:10.1126/science.1093616, ISSN 0036-8075, pages 1529 - 1531, XP002358690
OPPOSITION- HEIL F; HEMMI H; HOCHREIN H; AMPENBERGER F; KIRSCHNING C; AKIRA S; LIPFORD G; WAGNER H; BAUER S, "Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8", SCIENCE, (20040101), vol. 303, doi:10.1126/science.1093620, pages 1526 - 1529, XP002775831
OPPOSITION- Motorin Yuri, Grosjean Henri, "Appendix 1: Chemical Structures and Classification of Posttranscriptionally Modified Nucleosides in RNA ", Modification and Editing of RNA, ASM Press, (19980428), pages 543 - 549, doi:10.1128/9781555818296.app1, XP093176157

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents